🔎 Trials Near Me

Home › Hodgkin Lymphoma › Texas › Houston

Hodgkin Lymphoma clinical trials in Houston, TX

14 studies for Hodgkin Lymphoma are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

RecruitingPhase 2
  • M D Anderson Cancer Center, Houston
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05615636

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

RecruitingPhase 1/2
  • Research Site, Houston
Ages 12 and older · All sexes · Updated Sep 14, 2026 · NCT06137144

Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies

RecruitingPhase 1
  • The University of Texas M. D. Anderson Cancer Center, Houston
Ages 18 to 75 · All sexes · Updated Sep 8, 2026 · NCT07444632

Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL

RecruitingPhase 2
  • UT MD Anderson, Houston
Ages 2 to 21 · All sexes · Updated Aug 31, 2026 · NCT07551583

Personalized NK Cell Therapy in CBT

RecruitingPhase 2
  • M D Anderson Cancer Center, Houston
Ages 15 to 80 · All sexes · Updated Jul 30, 2026 · NCT02727803

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

RecruitingPhase 1
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
Ages 12 to 75 · All sexes · Updated Jul 20, 2026 · NCT06176690

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
  • M.D. Anderson Cancer Center, Houston
  • Texas Children's Hospital - Baylor Medical Center, Houston
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma

RecruitingPhase 1
  • Harris Health System - Ben Taub General Hospital/Smith Clinic, Houston
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
  • and 1 more
All ages · All sexes · Updated Jun 25, 2026 · NCT04664179

CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)

RecruitingPhase 1
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
Ages 12 to 75 · All sexes · Updated Jun 10, 2026 · NCT02917083

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

RecruitingObservational study
  • Texas Children's Hospital, Houston
Ages 0 to 38 · All sexes · Updated Jun 4, 2026 · NCT06131801

A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma

RecruitingPhase 2Healthy volunteers welcome
  • MD Anderson Cancer Center, Houston
Ages 1 and older · All sexes · Updated May 18, 2026 · NCT05355051

Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

RecruitingPhase 1
  • Harris Health System (includes ben Taub General Hospital and Smith), Houston
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
All ages · All sexes · Updated Mar 2, 2026 · NCT01555892

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RecruitingPhase 1
  • Texas Children's Hospital/Baylor College of Medicine, Houston
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770

About Hodgkin Lymphoma

Hodgkin lymphoma is a type of lymphoma, cancer of the lymph system. It is serious but can usually be cured if found and treated early. Learn more.

More about Hodgkin Lymphoma on MedlinePlus

Hodgkin Lymphoma trials in other cities

Other studies in Houston

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.